Skip to content

Comparison of Carbetocin with Oxytocin in preventing postpartum hemorrhage after normal vaginal delivery

Comparison of Carbetocin with Oxytocin in Active Management of Third Stage of labour in normal vaginal delivery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055317
Enrollment
109
Registered
2023-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Carbetocin: Carbetocin is a long acting synthetic analogue of oxytocin.It has been added to DCGI list of essential medicines for prevention of postpartum hemorrhage in 2020 It is given

Sponsors

Nivya Mercy Anil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All nulliparous singleton cephalic pregnancies who have completed 37weeks of gestation and induced for labour

Exclusion criteria

Exclusion criteria: All antepartum hemorrhage,pregnancy complications like hypertensive disorders, gestational diabetes,premature rupture of membranes,hypersensitivity to active substances in drug,known bleeding or coagulation disorders,operative delivery,uterine overdistension(suspected macrosomia,polyhydraminos),intrapartum fever.

Design outcomes

Primary

MeasureTime frame
Primary outcome is bloodloss upto 500ml within 24hours of delivery Pulse rate,Blood Pressure,Hemoglobin on postnatal day 3,use of any additional uterotonics,need for any surgical interventionsTimepoint: Within 24hours of delivery

Secondary

MeasureTime frame
Blood loss more than 500ml after delivery,need for additional uterotonic agents,blood transfusion,surgical intervention,Hemoglobin fall,any adverse drug effects like flushing,vomiting,abdominal pain,dizziness,shivering & headacheTimepoint: 72hours postpartum

Countries

India

Contacts

Public ContactNIVYA MERCY ANIL

MALANKARA ORTHODOX SYRIAN CHURCH HOSPITAL KOLENCHERY

drpreetha69@gmail.com9447987840

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026